Medicare Enrolled
Dr. Vagharshak Pilossyan, M.D.
Family Medicine · Van Nuys, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pilossyan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pilossyan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pilossyan
Dr. Vagharshak Pilossyan is a family medicine specialist in Van Nuys, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Pilossyan performed 11,668 Medicare services across 3,557 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pilossyan received a total of $31,949 from 82 pharmaceutical and/or device companies across 1163 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pilossyan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in CA
$31,949 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,668
Medicare services
Top 1% in CA for family medicine
3,557
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~614 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
7,741 | $71 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,034 | $100 | $200 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
929 | $8 | $20 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
419 | $140 | $250 |
| Annual depression screening | 396 | $21 | $75 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
349 | $35 | $120 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
310 | $45 | $120 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
180 | $11 | $120 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
95 | $65 | $200 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
63 | $178 | $350 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
57 | $101 | $300 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
40 | $179 | $300 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
20 | $88 | $300 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
18 | $145 | $450 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
17 | $231 | $450 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$31,949
Total received (2018-2024)
Avg $4,564/year across 7 years
Top 1% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
82
Companies
1,163
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$30,723 (96.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,226 (3.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,324
2023
$5,037
2022
$5,168
2021
$5,118
2020
$2,277
2019
$5,086
2018
$4,940
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$669
Regeneron Healthcare Solutions, Inc.
$437
ABBVIE INC.
$415
Ardelyx, Inc.
$319
Lilly USA, LLC
$271
Otsuka America Pharmaceutical, Inc.
$226
Radius Health, Inc.
$214
Abbott Laboratories
$199
Bayer Healthcare Pharmaceuticals Inc.
$183
Edwards Lifesciences Corporation
$180
AstraZeneca Pharmaceuticals LP
$170
Novartis Pharmaceuticals Corporation
$145
IDORSIA PHARMACEUTICALS US INC
$119
IRONWOOD PHARMACEUTICALS, INC
$109
GlaxoSmithKline, LLC.
$105
Almatica Pharma LLC
$54
Eisai Inc.
$52
Esperion Therapeutics, Inc.
$50
Phathom Pharmaceuticals, Inc.
$48
Sumitomo Pharma America, Inc.
$44
Janssen Biotech, Inc.
$36
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$33
Dexcom, Inc.
$31
SHIELD THERAPEUTICS INC
$26
Novo Nordisk Inc
$24
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Takeda Pharmaceuticals U.S.A., Inc.
$22
ANI Pharmaceuticals, Inc.
$22
Kiniksa Pharmaceuticals International, plc
$21
Xeris Pharmaceuticals, Inc.
$21
E.R. Squibb & Sons, L.L.C.
$15
CeQur Corporation
$15
Top 3 companies account for 35.2% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$4,906
AstraZeneca Pharmaceuticals LP
$2,962
Regeneron Healthcare Solutions, Inc.
$1,802
Lilly USA, LLC
$1,750
GlaxoSmithKline, LLC.
$1,419
Amarin Pharma Inc.
$1,384
Biohaven Pharmaceuticals, Inc.
$1,226
Novo Nordisk Inc
$1,090
ABBVIE INC.
$1,069
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,061
Novartis Pharmaceuticals Corporation
$808
Boehringer Ingelheim Pharmaceuticals, Inc.
$705
Esperion Therapeutics, Inc.
$578
AbbVie Inc.
$525
Janssen Pharmaceuticals, Inc
$512
Radius Health, Inc.
$485
Bayer Healthcare Pharmaceuticals Inc.
$468
Bayer HealthCare Pharmaceuticals Inc.
$455
Merck Sharp & Dohme Corporation
$448
Neurocrine Biosciences, Inc.
$443
Takeda Pharmaceuticals U.S.A., Inc.
$422
Allergan Inc.
$373
SANOFI-AVENTIS U.S. LLC
$360
PFIZER INC.
$347
Ardelyx, Inc.
$342
Abbott Laboratories
$327
Otsuka America Pharmaceutical, Inc.
$319
Astellas Pharma US Inc
$308
Ironwood Pharmaceuticals, Inc
$298
Horizon Therapeutics plc
$294
IDORSIA PHARMACEUTICALS US INC
$294
Nestle HealthCare Nutrition Inc.
$292
Merck Sharp & Dohme LLC
$289
Synergy Pharmaceuticals Inc
$257
Almatica Pharma LLC
$218
Hikma Pharmaceuticals USA
$208
Corium, LLC
$194
Daiichi Sankyo Inc.
$191
Janssen Biotech, Inc.
$191
Edwards Lifesciences Corporation
$180
Allergan, Inc.
$175
IRONWOOD PHARMACEUTICALS, INC
$156
Avanir Pharmaceuticals, Inc.
$151
E.R. Squibb & Sons, L.L.C.
$127
West-Ward Pharmaceuticals
$117
Gilead Sciences, Inc.
$113
Mannkind Corporation
$88
Phathom Pharmaceuticals, Inc.
$70
VIVUS, Inc.
$69
KVK-Tech, Inc.
$68
MannKind Corporation
$66
Biogen, Inc.
$66
Eisai Inc.
$65
Xeris Pharmaceuticals, Inc.
$61
ITI, Inc.
$53
ARALEZ PHARMACEUTICALS US INC.
$45
RedHill Biopharma Inc.
$45
Sumitomo Pharma America, Inc.
$44
Celgene Corporation
$42
Pulmonx Corporation
$36
Horizon Pharma plc
$35
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$33
Lundbeck LLC
$32
Genentech USA, Inc.
$32
Dexcom, Inc.
$31
UROVANT SCIENCES INC
$27
SHIELD THERAPEUTICS INC
$26
Medtronic Vascular, Inc.
$25
Phadia US Inc.
$23
ANI Pharmaceuticals, Inc.
$22
CMP Pharma, Inc.
$22
Kiniksa Pharmaceuticals International, plc
$21
Aurinia Pharma U.S., Inc.
$20
Philips Electronics North America Corporation
$18
ARBOR PHARMACEUTICALS, INC.
$18
Mylan Specialty L.P.
$17
Shionogi Inc
$17
Teva Pharmaceuticals USA, Inc.
$16
CeQur Corporation
$15
Scilex Pharmaceuticals Inc.
$15
Circassia Pharmaceuticals Inc
$14
SCILEX PHARMACEUTICALS INC.
$13
Top 3 companies account for 30.3% of all-time payments
Associated products mentioned in payments ›
ABILIFY MYCITE · ACCRUFER · ADUHELM · AFREZZA · AMPLATZER · ANORO · ANORO ELLIPTA · AREXVY · AVSOLA · Adlarity · Aemcolo · Amitiza · Arcalyst · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYDUREON · BYSTOLIC · CAPLYTA · CHANTIX · CHARTIS CATHETER · COBENFY · COLOGUARD · COSENTYX · CREON · Carospir · CeQur Simplicity · DUPIXENT · DUZALLO · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Endurant · FARXIGA · FASENRA · GEMTESA · GRALISE · GVOKE HYPOPEN · Horizant · IBSRELA · ILARIS · INGREZZA · INJECTAFER · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · LOKELMA · LOREEV XR · LUCEMYRA · LUPKYNIS · LYRICA · Leqembi · Linzess · MOUNJARO · MYRBETRIQ · Mitigare · Movantik · Myrbetriq · NEXLETOL · NEXLIZET · NUCALA · NUEDEXTA · NURTEC ODT · Otezla · Ozempic · PANCREAZE · PENNSAID · PRALUENT · PURIFIED CORTROPHIN GEL · Prolia · QULIPTA · QUVIVIQ · QVAR · Quadra Assura CRT Defibrillator · RAYOS · RELISTOR · REXULTI · RINVOQ · RYBELSUS · Repatha · Rybelsus · SAPIEN 3 Ultra RESILIA · SHINGRIX · SOLIQUA 100/33 · STEGLATRO · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · Symproic · TALTZ · TEZSPIRE · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TREMFYA · TRINTELLIX · TRULANCE · TRULICITY · TUDORZA PRESSAIR · Tresiba · Trintellix · Trulance · Tymlos · UBRELVY · VERQUVO · VIBERZI · VIIBRYD · VOQUEZNA · VRAYLAR · Vascepa · Victoza · XARELTO · XIFAXAN · XIFAXANIBSD · XIFIXAN · Xofluza · Yupelri · ZENPEP · ZONTIVITY · ZTLido · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
2,546
Per 100K population
25.9
County median income
$87,760
Nearest hospital
VALLEY PRESBYTERIAN HOSPITAL
1.9 mi
1.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pilossyan is a clinical cardiology specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement in the top 1% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pilossyan experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Pilossyan performed 7,741 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pilossyan receive payments from pharmaceutical companies?
Yes. Dr. Pilossyan received a total of $31,949 from 82 companies across 1,163 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pilossyan's costs compare to other family medicine physicians in Van Nuys?
Dr. Pilossyan's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pilossyan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Van Nuys
Browse family medicine physicians in Van Nuys ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology